Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil vs sufentanil + remifentanil for anesthesia induction in pediatric tonsil surgery
ChiCTR2400090213Phase 4Not yet recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Tonsillar hyperplasia and adenoidal hypertrophy comparing Group S (sufentanil induction) with Group R (sufentanil + remifentanil induction) (2 arms). Primary endpoint: Postoperative recovery time of children. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
sufentanilremifentanil
03
Conditions
Tonsillar hyperplasiaadenoidal hypertrophy
Beyond the preview
Go deeper on ChiCTR2400090213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090213.